Physician profile
Avinash Chenam
NPI 1841502986
$75,330.10
in general payments reported to CMS, 2019-2025
42 companies · $6,312 in 2025
The $6,312 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,168 · 2020: $945 · 2021: $1,334 · 2022: $4,387 · 2023: $36K · 2024: $24K · 2025: $6,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $50K · Food and Beverage: $6,913 · Travel and Lodging: $4,751 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $50,332.00 |
| Food and Beverage | $6,913.24 |
| Travel and Lodging | $4,751.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $64,091.56 | 2020-2025 | Da Vinci Surgical System, Davinci Xi |
| Procept Biorobotics Corporation | $2,539.21 | 2024-2025 | Aquabeam System |
| Biotissue Holdings INC. | $1,418.54 | 2021-2025 | |
| Boston Scientific Corporation | $1,404.09 | 2019-2021 | |
| Abbvie INC. | $831.51 | 2019-2025 | |
| Davol INC. | $538.83 | 2023-2025 | Arista, Arista Ah Flexitip |
| Astellas Pharma US INC | $514.64 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $433.16 | 2019-2025 | Provenge |
| Pfizer INC. | $411.31 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $362.54 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $322.47 | 2019-2025 | |
| Janssen Biotech, INC. | $270.82 | 2021-2025 | Erleada, Akeega, Balversa |
| Tolmar Pharmaceuticals, INC. | $259.92 | 2019-2021 | |
| Myovant Sciences INC. | $252.73 | 2021-2022 | |
| Tolmar, INC. | $199.75 | 2023-2025 | Eligard |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $187.77 | 2020-2023 | Speedicath |
| Teleflex LLC | $142.74 | 2021-2023 | Urolift |
| Urogen Pharma, INC. | $120.85 | 2021-2025 | |
| Blue Earth Diagnostics | $108.46 | 2019-2023 | |
| Agiliti Health, INC. | $84.90 | 2019 | |
| Olympus America INC. | $82.39 | 2019 | |
| Baxter Healthcare | $78.95 | 2020-2024 | Tisseel |
| Novartis Pharmaceuticals Corporation | $74.48 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $64.74 | 2022-2025 | Bard Urinary Drainage Bag |
| Neotract INC. | $50.58 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $48.07 | 2019-2025 | Adstiladrin |
| Immunitybio, INC. | $45.77 | 2025 | |
| Photocure INC | $44.36 | 2020 | |
| Progenics Pharmaceuticals, INC. | $42.32 | 2025 | |
| Laborie Medical Technologies Corp. | $38.86 | 2023 | |
| Axonics, INC. | $35.55 | 2024 | Axonics |
| Hollister Incorporated | $29.05 | 2020 | |
| Ethicon US, LLC | $28.91 | 2020-2025 | Stratafix, Ethicon, Vistaseal |
| Sun Pharmaceutical Industries INC. | $25.70 | 2019 | |
| Foundation Medicine, INC. | $25.59 | 2021-2022 | |
| Integra Lifesciences Corporation | $22.94 | 2023 | Medihoney, Biofix, Biodrestore |
| Urovant Sciences INC | $20.06 | 2022 | |
| Convatec INC. | $19.56 | 2023 | |
| Travere Therapeutics, INC. | $17.66 | 2019 | |
| Antares Pharma, INC. | $14.15 | 2022 | |
| Merck Sharp & Dohme LLC | $12.96 | 2023 | Keytruda, Lynparza, Welireg |
| Myriad Genetic Laboratories, INC. | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Chenam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.